🇺🇸 FDA
Pipeline program

Letrozole

21-194

Phase 1 small_molecule terminated

Quick answer

Letrozole for Metastatic Breast Cancer is a Phase 1 program (small_molecule) at Context Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
Context Therapeutics
Indication
Metastatic Breast Cancer
Phase
Phase 1
Modality
small_molecule
Status
terminated

Clinical trials